Summary by Futu AI
The Vanguard Group has filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Ginkgo Bioworks Holdings, Inc. Class A common stock. As of December 29, 2023, The Vanguard Group owns an aggregate amount of 132,779,676 shares, representing 8.20% of the class. This filing, dated February 13, 2024, shows that The Vanguard Group has shared voting power over 461,957 shares and sole dispositive power over 130,958,928 shares, with an additional shared dispositive power over 1,820,748 shares. The filing asserts that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing the control of the issuer.